cached image

Agneta Nordberg, MD PhD - Publications

Affiliations: 
Neurobiology, Care Sciences and Society Karolinska Institute, Stockholm, Sweden 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=86
Website:
http://ki.se/ki/jsp/polopoly.jsp?d=34701&a=101537&l=en

263 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, ... ... Nordberg A, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216  0.356
2021 Kumar A, Fontana IC, Nordberg A. Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease. Journal of Neurochemistry. PMID 34931315 DOI: 10.1111/jnc.15565  0.378
2021 Bucci M, Chiotis K, Nordberg A. Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Molecular Psychiatry. PMID 34593971 DOI: 10.1038/s41380-021-01263-2  0.748
2021 Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter M, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, ... Nordberg A, et al. Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34546388 DOI: 10.1007/s00259-021-05549-z  0.676
2021 Colato E, Chiotis K, Ferreira D, Mazrina MS, Lemoine L, Mohanty R, Westman E, Nordberg A, Rodriguez-Vieitez E. Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 34511502 DOI: 10.3233/JAD-210614  0.768
2021 Murugan NA, Nordberg A, Ågren H. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy. Acs Chemical Neuroscience. 12: 2437-2447. PMID 34152739 DOI: 10.1021/acschemneuro.0c00340  0.309
2021 Almkvist O, Brüggen K, Nordberg A. Subcortical and Cortical Regions of Amyloid-β Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients. Journal of Alzheimer's Disease : Jad. PMID 33967046 DOI: 10.3233/JAD-201612  0.585
2021 Bellaver B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, Rodriguez-Vieitez E, Nordberg A, Pellerin L, Rosa-Neto P, Leffa DT, Zimmer ER. Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis. Neurology. PMID 33952650 DOI: 10.1212/WNL.0000000000012109  0.656
2021 Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet. Neurology. PMID 33933186 DOI: 10.1016/S1474-4422(21)00066-1  0.337
2021 Kumar A, Koistinen NA, Malarte ML, Nennesmo I, Ingelsson M, Ghetti B, Lemoine L, Nordberg A. Astroglial tracer BU99008 detects multiple binding sites in Alzheimer's disease brain. Molecular Psychiatry. PMID 33888872 DOI: 10.1038/s41380-021-01101-5  0.324
2021 Bucci M, Savitcheva I, Farrar G, Salvadó G, Collij L, Doré V, Gispert JD, Gunn R, Hanseeuw B, Hansson O, Shekari M, Lhommel R, Molinuevo JL, Rowe C, Sur C, ... ... Nordberg A, et al. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [F]flutemetamol amyloid PET images. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33844055 DOI: 10.1007/s00259-021-05311-5  0.312
2021 Ni R, Röjdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, Nordberg A. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue. Journal of Alzheimer's Disease : Jad. PMID 33749648 DOI: 10.3233/JAD-201344  0.74
2021 Chiotis K, Dodich A, Boccardi M, Festari C, Drzezga A, Hansson O, Ossenkoppele R, Frisoni G, Garibotto V, Nordberg A. Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33723628 DOI: 10.1007/s00259-021-05277-4  0.735
2021 Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter MA, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, ... Nordberg A, et al. The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33688996 DOI: 10.1007/s00259-020-05120-2  0.695
2021 Bischof GN, Dodich A, Boccardi M, van Eimeren T, Festari C, Barthel H, Hansson O, Nordberg A, Ossenkoppele R, Sabri O, Giovanni BFG, Garibotto V, Drzezga A. Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33590274 DOI: 10.1007/s00259-020-05156-4  0.379
2021 Villemagne VL, Barkhof F, Garibotto V, Landau SM, Nordberg A, van Berckel BNM. Molecular Imaging Approaches in Dementia. Radiology. 200028. PMID 33464184 DOI: 10.1148/radiol.2020200028  0.331
2020 Mohanty R, Mårtensson G, Poulakis K, Muehlboeck JS, Rodriguez-Vieitez E, Chiotis K, Grothe MJ, Nordberg A, Ferreira D, Westman E. Comparison of subtyping methods for neuroimaging studies in Alzheimer's disease: a call for harmonization. Brain Communications. 2: fcaa192. PMID 33305264 DOI: 10.1093/braincomms/fcaa192  0.702
2020 Sala A, Nordberg A, Rodriguez-Vieitez E. Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity. Molecular Psychiatry. PMID 33303945 DOI: 10.1038/s41380-020-00950-w  0.349
2020 Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, ... ... Nordberg A, et al. Amyloid-PET and F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet. Neurology. 19: 951-962. PMID 33098804 DOI: 10.1016/S1474-4422(20)30314-8  0.362
2020 Smailovic U, Koenig T, Savitcheva I, Chiotis K, Nordberg A, Blennow K, Winblad B, Jelic V. Regional disconnection in Alzheimer dementia and amyloid positive MCI: Association of EEG functional connectivity and brain glucose metabolism. Brain Connectivity. PMID 33073602 DOI: 10.1089/brain.2020.0785  0.741
2020 Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, Delrieu J, Dubois B, Kivipelto M, Nordberg A, Schott JM, van der Flier WM, Vellas B, Jessen F, Scheltens P, et al. Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32815289 DOI: 10.1002/Alz.12132  0.354
2020 Perini G, Rodriguez-Vieitez E, Kadir A, Sala A, Savitcheva I, Nordberg A. Clinical impact of F-FDG-PET among memory clinic patients with uncertain diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32734458 DOI: 10.1007/S00259-020-04969-7  0.374
2020 Chiotis K, Savitcheva I, Poulakis K, Saint-Aubert L, Wall A, Antoni G, Nordberg A. [F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease. Molecular Psychiatry. PMID 32616831 DOI: 10.1038/S41380-020-0815-4  0.833
2020 Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9. Molecular Psychiatry. PMID 32581318 DOI: 10.1038/S41380-020-0817-2  0.715
2020 Vilaplana E, Rodriguez-Vieitez E, Ferreira D, Montal V, Almkvist O, Wall A, Lleó A, Westman E, Graff C, Fortea J, Nordberg A. Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease. Neurology. PMID 32291295 DOI: 10.1212/Wnl.0000000000009405  0.632
2020 Kuang G, Murugan NA, Zhou Y, Nordberg A, Agren H. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils. Acs Chemical Neuroscience. PMID 32069017 DOI: 10.1021/Acschemneuro.9B00578  0.377
2020 Ferreira D, Nordberg A, Westman E. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis. Neurology. PMID 32047067 DOI: 10.1212/WNL.0000000000009058  0.301
2019 Karami A, Eriksdotter M, Kadir A, Almkvist O, Nordberg A, Darreh-Shori T. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease. Frontiers in Molecular Neuroscience. 12: 239. PMID 31680850 DOI: 10.3389/Fnmol.2019.00239  0.608
2019 Lana E, Gellerbring A, Jung S, Nordberg A, Unger Lithner C, Darreh-Shori T. Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype. Frontiers in Molecular Neuroscience. 12: 176. PMID 31417354 DOI: 10.3389/Fnmol.2019.00176  0.429
2019 Almkvist O, Rodriguez-Vieitez E, Thordardottir S, Nordberg A, Viitanen M, Lannfelt L, Graff C. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes. Neurobiology of Aging. 82: 40-47. PMID 31386938 DOI: 10.1016/J.Neurobiolaging.2019.06.010  0.567
2019 Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, ... ... Nordberg A, et al. Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset. Journal of Neurology. PMID 31267207 DOI: 10.1007/S00415-019-09441-7  0.762
2019 Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31230910 DOI: 10.1016/J.Jalz.2019.02.004  0.415
2019 Murugan NA, Chiotis K, Rodriguez-Vieitez E, Lemoine L, Ågren H, Nordberg A. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30919054 DOI: 10.1007/S00259-019-04305-8  0.698
2019 Leuzy A, Savitcheva I, Chiotis K, Lilja J, Andersen P, Bogdanovic N, Jelic V, Nordberg A. Clinical impact of [F]flutemetamol PET among memory clinic patients with an unclear diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30915522 DOI: 10.1007/S00259-019-04297-5  0.728
2019 Jonasson M, Wall A, Chiotis K, Leuzy A, Eriksson J, Antoni G, Nordberg A, Lubberink M. Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [F]THK5317 PET. Neuroimage. Clinical. 22: 101681. PMID 30710871 DOI: 10.1016/J.Nicl.2019.101681  0.726
2019 Zou R, Kuang G, Agren H, Nordberg A, Långström B, Tu Y. Free Energy Profile for Penetration of Pittsburgh Compound-B into the Amyloid β Fibril. Acs Chemical Neuroscience. PMID 30698013 DOI: 10.1021/Acschemneuro.8B00662  0.369
2019 Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Molecular Psychiatry. PMID 30635637 DOI: 10.1038/S41380-018-0342-8  0.789
2019 Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine. PMID 30611668 DOI: 10.1016/J.Molmed.2018.11.006  0.693
2019 Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K, Nordberg A. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30610252 DOI: 10.1007/S00259-018-4242-6  0.827
2019 Carter SF, Chiotis K, Nordberg A, Rodriguez-Vieitez E. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 46: 348-356. PMID 30515545 DOI: 10.1007/S00259-018-4217-7  0.809
2019 Darreh-Shori T, Kumar R, Kumar A, Murumkar P, Nag S, Jia Z, Arakawa R, Leuzy A, Lemoine L, Nordberg A, Yadav MR, Halldin C, Långström B. LIGANDS OF THE CORE ACETYLCHOLINE BIOSYNTHESIZING ENZYME, CHOLINE ACETYLTRANSFERASE, AS NOVEL AND POTENTIAL THERAPEUTIC AGENTS AND IN VIVO PET TRACERS FOR EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE Alzheimer's & Dementia. 15: P1630. DOI: 10.1016/J.Jalz.2019.06.4869  0.357
2018 Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, ... Nordberg A, et al. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathologica Communications. 6: 130. PMID 30477568 DOI: 10.1186/S40478-018-0624-Z  0.47
2018 Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, ... ... Nordberg A, et al. AMYPAD Diagnostic and Patient Management Study: Rationale and design. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30339801 DOI: 10.1016/J.Jalz.2018.09.003  0.409
2018 Oliveira F, Leuzy A, Castelhano J, Chiotis K, Hasselbalch SG, Rinne J, Mendonça A, Otto M, Lleó A, Santana I, Johansson J, Anderl-Straub S, Arnim C, Beer A, Blesa R, ... ... Nordberg A, et al. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species. Neuroimage. Clinical. 20: 603-610. PMID 30186764 DOI: 10.1016/J.Nicl.2018.08.023  0.767
2018 Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T, Shams M, Aspelin P, Kristoffersen-Wiberg M, Nordberg A, Wahlund LO, Westman E. The contribution of small vessel disease to subtypes of Alzheimer's disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiology of Aging. 70: 18-29. PMID 29935417 DOI: 10.1016/J.Neurobiolaging.2018.05.028  0.46
2018 Lilja J, Leuzy A, Chiotis K, Savitcheva I, Sörensen J, Nordberg A. Spatial normalization of [F]flutemetamol PET images utilizing an adaptive principal components template. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29903930 DOI: 10.2967/Jnumed.118.207811  0.714
2018 Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 232-236. PMID 29780868 DOI: 10.1016/J.Dadm.2018.01.007  0.744
2018 Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29752516 DOI: 10.1007/S00259-018-4012-5  0.788
2018 Thordardottir S, Rodriguez-Vieitez E, Almkvist O, Ferreira D, Saint-Aubert L, Kinhult-Ståhlbom A, Thonberg H, Schöll M, Westman E, Wall A, Eriksdotter M, Zetterberg H, Blennow K, Nordberg A, Graff C. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. Alzheimer's Research & Therapy. 10: 45. PMID 29747683 DOI: 10.1186/S13195-018-0374-Y  0.773
2018 Murugan NA, Nordberg A, Ågren H. Different PET tau tracers bind to multiple binding sites on the tau fibril : Insight from computational modeling. Acs Chemical Neuroscience. PMID 29630333 DOI: 10.1021/Acschemneuro.8B00093  0.322
2018 Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, ... ... Nordberg A, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009  0.424
2018 Rodriguez-Vieitez E, Nordberg A. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Methods in Molecular Biology (Clifton, N.J.). 1750: 231-251. PMID 29512077 DOI: 10.1007/978-1-4939-7704-8_16  0.52
2018 Ni R, Ji B, Ono M, Sahara N, Zhang MR, Aoki I, Nordberg A, Suhara T, Higuchi M. Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29419480 DOI: 10.2967/Jnumed.117.201632  0.745
2017 Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29268078 DOI: 10.1016/J.Jalz.2017.11.008  0.825
2017 Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains. Alzheimer's Research & Therapy. 9: 96. PMID 29229003 DOI: 10.1186/S13195-017-0325-Z  0.401
2017 Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Nordberg A, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391  0.435
2017 Balamurugan K, Murugan NA, Långström B, Nordberg A, Ågren H. Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers- Insight from Molecular Modeling Studies. Acs Chemical Neuroscience. PMID 28898051 DOI: 10.1021/Acschemneuro.7B00215  0.417
2017 Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X  0.803
2017 Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's Disease : Jad. 59: 603-614. PMID 28671117 DOI: 10.3233/Jad-170158  0.803
2017 Heurling K, Leuzy A, Jonasson M, Frick A, Zimmer ER, Nordberg A, Lubberink M. Quantitative positron emission tomography in brain research. Brain Research. PMID 28652218 DOI: 10.1016/J.Brainres.2017.06.022  0.422
2017 Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. Molecular Psychiatry. 23: 1666-1673. PMID 28507319 DOI: 10.1038/Mp.2017.108  0.848
2017 Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by (3)H-THK5117 and (3)H-deprenyl autoradiography. Scientific Reports. 7: 45496. PMID 28374768 DOI: 10.1038/Srep45496  0.714
2017 Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 285-295. PMID 28341066 DOI: 10.1016/J.Jalz.2016.09.009  0.451
2017 Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 274-284. PMID 28341065 DOI: 10.1016/J.Jalz.2016.09.008  0.434
2017 Chiotis K, Saint-Aubert L, Boccardi M, Gietl A, Picco A, Varrone A, Garibotto V, Herholz K, Nobili F, Nordberg A. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 214-227. PMID 28317650 DOI: 10.1016/J.Neurobiolaging.2016.07.012  0.827
2017 Garibotto V, Herholz K, Boccardi M, Picco A, Varrone A, Nordberg A, Nobili F, Ratib O. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 183-195. PMID 28317648 DOI: 10.1016/J.Neurobiolaging.2016.03.033  0.454
2017 Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging: present and future directions. Molecular Neurodegeneration. 12: 19. PMID 28219440 DOI: 10.1186/S13024-017-0162-3  0.84
2017 Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain : a Journal of Neurology. PMID 28087578 DOI: 10.1093/Brain/Aww339  0.741
2017 Kuang G, Zhou Y, Zou R, Halldin C, Nordberg A, Långström B, Ågren H, Tu Y. Characterization of the binding mode of the PET tracer [18F]ASEM to a chimera structure of the α7 nicotinic acetylcholine receptor Rsc Advances. 7: 19787-19793. DOI: 10.1039/C7Ra00496F  0.307
2017 Frisoni GB, Barkhof F, Farrar G, Raffa N, Gismondi R, Schmidt ME, Berkhof J, Boccardi M, Walker Z, Scheltens P, Schott JM, Molinuevo JL, Vellas B, Jessen F, Nordberg A, et al. THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET Alzheimer's & Dementia. 13: P1523. DOI: 10.1016/J.Jalz.2017.07.653  0.391
2017 Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [IC-P-178]: HEAD-TO-HEAD IN VIVO COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11 C]THK5351 VERSUS [11 C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P133-P133. DOI: 10.1016/J.Jalz.2017.06.2553  0.795
2017 Leuzy A, Chiotis K, Jelic V, Andersen P, Friman J, Lilja J, Savitcheva I, Nordberg A. Investigating The Clinical Impact Of [18F]Flutemetamol Pet In A Tertiary Memory Clinic Setting In Patients With Uncertain Diagnosis Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2288  0.693
2017 Lemoine L, Gillberg P, Svedberg M, Stepanov V, Nag S, Tian H, Higuchi M, Halldin C, Nordberg A. [P4-274]: COMPARISON OF BINDING PROPERTIES OF THK5117, THK5351, PBB3 AND T807 IN AUTOPSIES OF ALZHEIMER DISEASE CASES Alzheimer's & Dementia. 13: P1390-P1390. DOI: 10.1016/J.Jalz.2017.06.2143  0.345
2017 Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [P2-366]: HEAD-TO-HEAD IN VIVO COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11 C]THK5351 VERSUS [11 C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P765-P765. DOI: 10.1016/j.jalz.2017.06.1021  0.612
2016 Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, Furumoto S, Mitsios N, Mulder J, Långström B, Nordberg A, Halldin C. Development of [(11)C]/[(3)H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand. Nuclear Medicine and Biology. 46: 50-53. PMID 28013122 DOI: 10.1016/J.Nucmedbio.2016.12.004  0.415
2016 Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693181 DOI: 10.1016/J.Jalz.2016.08.006  0.755
2016 Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A. Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease. Alzheimer's Research & Therapy. 8: 38. PMID 27683159 DOI: 10.1186/S13195-016-0204-Z  0.847
2016 Natarajan AM, Halldin C, Nordberg A, Långström B, Ågren H. The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid Specific Tracers. The Journal of Physical Chemistry Letters. PMID 27498616 DOI: 10.1021/Acs.Jpclett.6B01586  0.331
2016 Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, McConathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1316-22. PMID 27481605 DOI: 10.2967/Jnumed.116.174615  0.377
2016 Leuzy A, Chiotis K, Hasselbalch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-Branco M, Santana I, Johansson J, Anderl-Straub S, von Arnim CA, Beer A, Blesa R, Fortea J, ... ... Nordberg A, et al. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study. Brain : a Journal of Neurology. PMID 27401520 DOI: 10.1093/Brain/Aww160  0.719
2016 Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, ... Nordberg A, et al. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheimer's Research & Therapy. 8: 30. PMID 27389402 DOI: 10.1186/S13195-016-0195-9  0.561
2016 Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Wall A, Nordberg A. Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27107028 DOI: 10.1177/0271678X16645593  0.826
2016 Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. European Journal of Nuclear Medicine and Molecular Imaging. 43: 1686-99. PMID 26996778 DOI: 10.1007/S00259-016-3363-Z  0.843
2016 Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, ... ... Nordberg A, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4  0.414
2016 Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A. Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912447 DOI: 10.2967/Jnumed.115.168732  0.811
2016 Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 26813969 DOI: 10.1093/Brain/Awv404  0.827
2016 Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson JP, Sörensen J, Antoni G, Nordberg A, Lubberink M. Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26795290 DOI: 10.2967/Jnumed.115.158519  0.842
2016 Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. 43: 362-73. PMID 26440450 DOI: 10.1007/S00259-015-3208-1  0.443
2016 Chiotis K, Saint-Aubert L, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau pet imaging in neurodegenerative tauopathies – a multimodal paradigm Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.125  0.817
2016 Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Nordberg A. Comparison of Early-Phase (S)-[18F]THK5117 and [11C]PIB PET imaging to assess brain perfusion in Alzheimer’s disease Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.095  0.821
2016 Leuzy A, Chiotis K, Pannee J, Hasselbalch S, Rinne J, Castelo-Branco M, Mendonca A, Santana I, Bisa AL, Johansson J, Otto M, Portelius E, Zetterberg H, Blennow K, Nordberg A. Improved concordance between [11C]PIB PET and CSF Aβ42 using Aβ42/Aβ40: findings from a multicentre European memory clinic population Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.084  0.729
2016 Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Almkvist O, Wall A, Nordberg A. Early-Phase [11C]Pib Pet Is Comparable To [18F]Fdg Pet As A Marker Of Disease Progression In Alzheimer'S Disease Alzheimers & Dementia. 12: 1171. DOI: 10.1016/J.Jalz.2016.07.094  0.833
2016 Nordberg A, Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Almkvist O, Wall A, Antoni G. Longitudinal Changes In Regional Tau Deposition In Alzheimer'S Disease And Other Tauopathies Measured By [18F]-Tkh5317 Pet In A Multi-Tracer Design Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.645  0.832
2016 Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Wall A, Antoni G, Nordberg A. Tau Pet Imaging In Non-Alzheimer’S Disease Dementia: A Multimodal Paradigm Alzheimers & Dementia. 12: 137. DOI: 10.1016/J.Jalz.2016.06.1925  0.831
2016 Saint-Aubert L, Chiotis K, Wall A, Almkvist O, Nordberg A. P1-306: Association Between in Vivo TAU Deposition Measured Using [18F]THK5317 Pet and Cognitive Functions in Alzheimer's Disease Alzheimer's & Dementia. 12: P539-P540. DOI: 10.1016/J.Jalz.2016.06.1056  0.837
2015 Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific Reports. 5: 16404. PMID 26553227 DOI: 10.1038/Srep16404  0.841
2015 Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, et al. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. PMID 26468410 DOI: 10.1212/Wnl.0000000000002081  0.701
2015 Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment. Journal of Alzheimer's Disease : Jad. 47: 691-704. PMID 26401704 DOI: 10.3233/Jad-132474  0.652
2015 Farid K, Carter SF, Rodriguez-Vieitez E, Almkvist O, Andersen P, Wall A, Blennow K, Portelius E, Zetterberg H, Nordberg A. Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition. Journal of Alzheimer's Disease : Jad. 47: 661-7. PMID 26401701 DOI: 10.3233/Jad-141965  0.782
2015 Kuang G, Murugan NA, Tu Y, Nordberg A, Ågren H. Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-β(1-42) Fibril by Molecular Docking and Molecular Dynamics Methods. The Journal of Physical Chemistry. B. 119: 11560-7. PMID 26266837 DOI: 10.1021/Acs.Jpcb.5B05964  0.341
2015 Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue. Acta Neuropathologica Communications. 3: 40. PMID 26134112 DOI: 10.1186/S40478-015-0220-4  0.755
2015 Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-506. PMID 26130168 DOI: 10.1007/S00259-015-3115-5  0.815
2015 Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, ... ... Nordberg A, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669  0.511
2015 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Nordberg A, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668  0.334
2015 Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1119-32. PMID 25893384 DOI: 10.1007/S00259-015-3047-0  0.732
2015 Andreasen N, Simeoni M, Ostlund H, Lisjo PI, Fladby T, Loercher AE, Byrne GJ, Murray F, Scott-Stevens PT, Wallin A, Zhang YY, Bronge LH, Zetterberg H, Nordberg AK, Yeo AJ, et al. First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study. Plos One. 10: e0098153. PMID 25789616 DOI: 10.1371/journal.pone.0098153  0.304
2015 Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, ... Nordberg A, et al. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25676388 DOI: 10.1016/J.Jalz.2014.11.008  0.38
2015 Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 1077-88. PMID 25649653 DOI: 10.3233/Jad-142952  0.851
2015 Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25646957 DOI: 10.1016/J.Jalz.2014.12.001  0.813
2015 Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, ... Nordberg A, et al. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology. 84: 508-15. PMID 25568301 DOI: 10.1212/Wnl.0000000000001209  0.755
2015 Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, ... ... Nordberg A, et al. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. European Journal of Nuclear Medicine and Molecular Imaging. 42: 438-46. PMID 25412766 DOI: 10.1007/S00259-014-2955-8  0.471
2015 Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, ... ... Nordberg A, et al. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 195-206.e1. PMID 25150733 DOI: 10.1016/J.Jalz.2014.06.006  0.505
2015 Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Blennow K, Langstrom B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment Journal of Alzheimer's Disease. 47: 691-704. DOI: 10.3233/JAD-132474  0.541
2015 Ni R, Gillberg P, Viitanen M, Myllykangas L, Bogdanovic N, Nennesmo I, Långström B, Nordberg A. P4-254: Characterization of regional binding of clinical amyloid tracers in autosomal dominant and sporadic Alzheimer's disease brains and their interactions with resveratrol Alzheimer's & Dementia. 11: P878-P878. DOI: 10.1016/J.Jalz.2015.08.083  0.735
2015 Caroli A, Galluzzi S, Ferrari C, Prestia A, Flier WMvd, Ossenkoppele R, Berckel BNMv, Barkhof F, Teunissen CE, Wall A, Carter SF, Scholl M, Choo IH, Grimmer T, Redolfi A, ... Nordberg A, et al. Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.064  0.755
2015 Rodriguez-Vieitez E, Carter SF, Saint-Aubert L, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. IC-P-126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal-dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 11: P86-P86. DOI: 10.1016/J.Jalz.2015.06.148  0.825
2015 Varrone A, Nordberg A. Molecular imaging of neuroinflammation in Alzheimer’s disease Clinical and Translational Imaging. 3: 437-447. DOI: 10.1007/S40336-015-0137-8  0.49
2015 Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-1506. DOI: 10.1007/s00259-015-3115-5  0.652
2014 Almkvist O, Kadir A, Nordberg A. Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case. Neurocase. 1-10. PMID 25494540 DOI: 10.1080/13554794.2014.979835  0.646
2014 Murugan NA, Zale?ny R, Kongsted J, Nordberg A, Ågren H. Promising two-photon probes for in vivo detection of β amyloid deposits. Chemical Communications (Cambridge, England). 50: 11694-7. PMID 25141215 DOI: 10.1039/C4Cc03897E  0.37
2014 Choo IL, Carter SF, Schöll ML, Nordberg A. Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2120-6. PMID 25077930 DOI: 10.1007/S00259-014-2859-7  0.8
2014 Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, ... ... Nordberg A, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0  0.466
2014 Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B. Harmonized diagnostic criteria for Alzheimer's disease: recommendations. Journal of Internal Medicine. 275: 204-13. PMID 24605805 DOI: 10.1111/Joim.12199  0.419
2014 Chiotis K, Carter SF, Farid K, Nordberg A. P3-218: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P710-P711. DOI: 10.1016/j.jalz.2014.05.1309  0.629
2014 Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. P3-215: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P709-P710. DOI: 10.1016/j.jalz.2014.05.1306  0.714
2014 Eyjolfsdottir H, Per A, Lind G, Linderoth B, Karami A, Almkvist O, Andreasen N, Blennow K, Jelic V, Nordberg A, Sundström E, Wahlund L, Wall A, Wiberg MK, Winblad B, et al. Encapsulated Cell Biodelivery Of Ngf To Cholinergic Basal Forebrain In Alzheimer'S Disease Patients: A Dose-Escalation Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1063  0.571
2014 Chiotis K, Carter SF, Farid K, Nordberg A. IC-P-025: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P18-P18. DOI: 10.1016/J.Jalz.2014.05.029  0.78
2014 Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. IC-P-019: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P16-P16. DOI: 10.1016/J.Jalz.2014.05.023  0.724
2014 Ni R, Rodriguez-Vieitez E, Voytenko L, Marutle A, Nordberg A. Different Time Course Of Astrocytosis And Amyloid Deposition In Alzheimer'S Appswe Transgenice Mice: A Multi-Tracer Micropet Study Alzheimers & Dementia. 10: 253. DOI: 10.1016/J.Jalz.2014.04.394  0.725
2014 Caroli A, Frisoni G, Prestia A, Galluzzi S, Ferrari C, Flier WMVd, Ossenkoppele R, Berckel Bv, Barkhof F, Teunissen C, Wall A, Carter SF, Schöll M, Choo IH, Grimmer T, ... Nordberg A, et al. Mild Cognitive Impairment With Suspected Non Ad Pathology (Snap): Prediction Of Progression To Dementia Alzheimers & Dementia. 10: 19-19. DOI: 10.1016/J.Jalz.2014.04.230  0.771
2013 Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/Wnl.0B013E31829D86E8  0.436
2013 Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Journal of Neuroinflammation. 10: 90. PMID 23880036 DOI: 10.1186/1742-2094-10-90  0.749
2013 Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, LÃ¥ngström B, Almkvist O, Nordberg A. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease. Neurobiology of Aging. 34: 2465-81. PMID 23759148 DOI: 10.1016/J.Neurobiolaging.2013.04.027  0.57
2013 Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. Brain : a Journal of Neurology. 136: 2217-27. PMID 23757761 DOI: 10.1093/Brain/Awt142  0.718
2013 Lilja AM, Röjdner J, Mustafiz T, Thomé CM, Storelli E, Gonzalez D, Unger-Lithner C, Greig NH, Nordberg A, Marutle A. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels. Plos One. 8: e58752. PMID 23554921 DOI: 10.1371/Journal.Pone.0058752  0.365
2013 Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 80: 1048-56. PMID 23390179 DOI: 10.1212/Wnl.0B013E3182872830  0.732
2013 Lilja AM, Luo Y, Yu QS, Röjdner J, Li Y, Marini AM, Marutle A, Nordberg A, Greig NH. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease. Plos One. 8: e54887. PMID 23382994 DOI: 10.1371/Journal.Pone.0054887  0.35
2013 Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage. 70: 423-33. PMID 23261639 DOI: 10.1016/J.Neuroimage.2012.12.014  0.722
2013 Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's Disease : Jad. 33: 929-39. PMID 23047371 DOI: 10.3233/Jad-2012-121489  0.811
2013 Ni R, Marutle A, Nordberg A. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 33: 841-51. PMID 23042213 DOI: 10.3233/Jad-2012-121447  0.729
2013 Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, LÃ¥ngström B, Scheinin N, Karrasch M, NÃ¥gren K, Grimmer T, Miederer I, Edison P, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/S00259-012-2237-2  0.799
2013 Chiotis K, Carter S, Nordberg A. P1-320: Comparison of PiB-PET data to florbetapir-PET data acquired from cohorts at different research sites Alzheimer's & Dementia. 9: P275-P275. DOI: 10.1016/J.Jalz.2013.05.546  0.765
2013 Chiotis K, Carter S, Nordberg A. Comparison of PiB-PET data to florbetapir-PET data acquired from different patient cohorts at different research sites Alzheimers & Dementia. 9: 13. DOI: 10.1016/J.Jalz.2013.05.007  0.782
2013 Schöll M, Carter S, Westman E, Almkvist O, Wall A, Graff C, Långström B, Nordberg A. O4-07-02: Longitudinal multi-tracer positron emission tomography studies of astrocytosis, fibrillar amlyloid deposition and cerebral glucose metabolism during development of early-onset familial Alzheimer's disease Alzheimer's & Dementia. 9: P695-P695. DOI: 10.1016/J.Jalz.2013.04.372  0.806
2013 Rodriguez-Vieitez E, Ni R, Gulyás B, Toth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid deposition in Alzheimer’s disease Tg2576 APPswe transgenic mice: A multitracer microPET imaging study Alzheimers & Dementia. 9: 337. DOI: 10.1016/J.Jalz.2013.04.197  0.702
2012 Sugaya K, Youdim MB, Nordberg A, Rao KS. Neuroprotection and neuroregeneration in Alzheimer's disease. International Journal of Alzheimer's Disease. 2012: 864138. PMID 22737586 DOI: 10.1155/2012/864138  0.408
2012 Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, LÃ¥ngström B, Almkvist O, Graff C, Nordberg A. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology. 79: 229-36. PMID 22700814 DOI: 10.1212/Wnl.0B013E31825Fdf18  0.627
2012 Eriksdotter-Jönhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, Andreasen N, Blennow K, Bogdanovic N, Jelic V, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, et al. Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 33: 18-28. PMID 22377499 DOI: 10.1159/000336051  0.603
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, ... ... Nordberg A, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0  0.432
2012 Carter SF, Schöll M, Almkvist O, Wall A, Engler H, LÃ¥ngström B, Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 37-46. PMID 22213821 DOI: 10.2967/Jnumed.110.087031  0.789
2012 Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, LÃ¥ngström B, Nordberg A. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiology of Aging. 33: 198.e1-14. PMID 20688420 DOI: 10.1016/J.Neurobiolaging.2010.06.015  0.681
2011 Lithner CU, Hedberg MM, Nordberg A. Transgenic mice as a model for Alzheimer's disease. Current Alzheimer Research. 8: 818-31. PMID 21592052 DOI: 10.2174/156720511798192736  0.416
2011 Mustafiz T, Portelius E, Gustavsson MK, Hölttä M, Zetterberg H, Blennow K, Nordberg A, Lithner CU. Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice. Neuro-Degenerative Diseases. 8: 352-63. PMID 21346320 DOI: 10.1159/000323871  0.444
2011 Shafaati M, Marutle A, Pettersson H, Lövgren-Sandblom A, Olin M, Pikuleva I, Winblad B, Nordberg A, Björkhem I. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. Journal of Lipid Research. 52: 1004-10. PMID 21335619 DOI: 10.1194/Jlr.M014548  0.396
2011 Schöll M, Almkvist O, Bogdanovic N, Wall A, LÃ¥ngström B, Viitanen M, Nordberg A. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. Journal of Alzheimer's Disease : Jad. 24: 495-506. PMID 21297272 DOI: 10.3233/Jad-2011-101563  0.612
2011 Keller C, Kadir A, Forsberg A, Porras O, Nordberg A. Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 24: 109-23. PMID 21157026 DOI: 10.3233/Jad-2010-101290  0.427
2011 Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain : a Journal of Neurology. 134: 301-17. PMID 21149866 DOI: 10.1093/Brain/Awq349  0.641
2011 Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, et al. Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95: 579-93. PMID 21130138 DOI: 10.1016/J.Pneurobio.2010.11.005  0.401
2011 Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 23: 335-47. PMID 21116052 DOI: 10.3233/Jad-2010-101242  0.401
2011 Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, LÃ¥ngström B, Nordberg A. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiology of Aging. 32: 2320.e15-32. PMID 20538374 DOI: 10.1016/J.Neurobiolaging.2010.04.028  0.656
2011 Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, LÃ¥ngström B, Lannfelt L, Graff C, Nordberg A. Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiology of Aging. 32: 1388-99. PMID 19796846 DOI: 10.1016/J.Neurobiolaging.2009.08.016  0.64
2011 Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A. The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiology of Aging. 32: 1236-48. PMID 19713000 DOI: 10.1016/J.Neurobiolaging.2009.07.015  0.413
2011 Ng Y, Nordberg A, Carter S, Schöll M, Kadir A. P4-358: Different hierarchical cytoarchitectonic sub-type vulnerability to Aβ-deposits and gray matter loss in AD and MCI patients: A comparison between a young and old cohort Alzheimer's & Dementia. 7: e37-e38. DOI: 10.1016/J.Jalz.2011.09.173  0.762
2011 Thomé C, Ni R, Gillberg P, Marutle A, Nordberg A. P4-301: Evolution of fibrillar amyloid in relation to astro- and microgliosis and alterations in α7 nicotinic receptors in Alzheimer APPswe mice as studied with multi-tracer concept Alzheimer's & Dementia. 7: e16-e17. DOI: 10.1016/J.Jalz.2011.09.046  0.697
2011 Schöll M, Almkvist O, Graff C, Nordberg A. O2-06-08: Amyloid imaging in members of a family harbouring the Arctic APP mutation Alzheimer's & Dementia. 7: S303-S303. DOI: 10.1016/J.Jalz.2011.05.880  0.684
2011 Carter SF, Nordberg A, Schöll M, Almkvist O, Wall A, Engler H, Långström B. O1-07-05: Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG Alzheimer's & Dementia. 7: S110-S110. DOI: 10.1016/J.Jalz.2011.05.276  0.821
2011 Lithner CU, Hernandez C, Sweatt JD, Nordberg A. O3-05-05: Epigenetic effects of Aβ and the implication on the pathophysiology in Alzheimer's disease Alzheimer's & Dementia. 7: S508-S508. DOI: 10.1016/J.Jalz.2011.05.1420  0.395
2011 Ni R, Marutle A, Nordberg A. P2-487: Alpha7 nicotinic receptor agonists interrupt the interaction between fibrillar amyloid and nicotinic receptor in Alzheimer's brain Alzheimer's & Dementia. 7: S468-S468. DOI: 10.1016/J.Jalz.2011.05.1358  0.686
2011 Marutle A, Bergfors A, Ni R, Nennesmo I, Gillberg P, Nordberg A. P2-329: Laminar distributions of fibrillar β-amyloid and activated astrocytes in Alzheimer's disease autopsy brain: A quantitative autoradiography study Alzheimer's & Dementia. 7: S414-S415. DOI: 10.1016/J.Jalz.2011.05.1205  0.726
2010 Wicklund L, Leão RN, Strömberg AM, Mousavi M, Hovatta O, Nordberg A, Marutle A. Î’-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons. Plos One. 5: e15600. PMID 21179413 DOI: 10.1371/Journal.Pone.0015600  0.378
2010 Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neuro-Degenerative Diseases. 7: 379-88. PMID 20689242 DOI: 10.1159/000287954  0.417
2010 Degerman Gunnarsson M, Lindau M, Wall A, Blennow K, Darreh-Shori T, Basu S, Nordberg A, Larsson A, Lannfelt L, Basun H, Kilander L. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dementia and Geriatric Cognitive Disorders. 29: 204-12. PMID 20332638 DOI: 10.1159/000281832  0.483
2010 Forsberg A, Almkvist O, Engler H, Wall A, LÃ¥ngström B, Nordberg A. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Current Alzheimer Research. 7: 56-66. PMID 20205671 DOI: 10.2174/156720510790274446  0.664
2010 Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. P4-089: Investigating Astrocytes With C11-deuterium Deprenyl in Mild Cognitive Impairment and Mild Alzheimer's - A Multi-tracer Positron Emission Tomography Paradigm Alzheimer's & Dementia. 6: e48-e49. DOI: 10.1016/J.Jalz.2010.08.149  0.812
2010 Schöll M, Almkvist O, Wall A, Engler H, Kinhult-Ståhlbom A, Graff C, Nordberg A. Multitracer PET studies in kindreds with early-onset familial Alzheimer gene mutations Alzheimer's & Dementia. 6: S294. DOI: 10.1016/J.Jalz.2010.05.965  0.722
2009 Ferris S, Nordberg A, Soininen H, Darreh-Shori T, Lane R. Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment. Pharmacogenetics and Genomics. 19: 635-46. PMID 19617863 DOI: 10.1097/Fpc.0B013E32832F8C17  0.412
2009 Peskind E, Nordberg A, Darreh-Shori T, Soininen H. Safety of lumbar puncture procedures in patients with Alzheimer's disease. Current Alzheimer Research. 6: 290-2. PMID 19519311 DOI: 10.2174/156720509788486509  0.301
2009 Nordberg A, Darreh-Shori T, Peskind E, Soininen H, Mousavi M, Eagle G, Lane R. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Current Alzheimer Research. 6: 4-14. PMID 19199870 DOI: 10.2174/156720509787313961  0.402
2009 Svedberg MM, Hall H, Hellström-Lindahl E, Estrada S, Guan Z, Nordberg A, LÃ¥ngström B. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochemistry International. 54: 347-57. PMID 19162107 DOI: 10.1016/J.Neuint.2008.12.016  0.422
2009 Nordberg A, Forsberg A, Kadir A, Almkvist O, Engler H, Långström B. S.4.02 Time course in evolution of brain amyloid and its relation to cognitive impairment in Alzheimer's disease European Neuropsychopharmacology. 19: S125-S126. DOI: 10.1016/S0924-977X(09)70133-6  0.621
2009 Kadir A, Zetterberg H, Andreasen N, Almkvist O, Wall A, Forsberg A, Blennow K, Långström B, Nordberg A. IC-O2-03: Long-term effect of phenserine treatment in Alzheimer patients as assessed by PET and CSF biomarkers Alzheimer's & Dementia. 5: P6-P6. DOI: 10.1016/J.Jalz.2009.05.019  0.581
2009 Nordberg A, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Almkvist O, Scheinin N, Grimmer T, Okello A, Van Laere K, Hinz R, Carter SF, Kalbe E, Herholz K. IC-S1-03: PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study Alzheimer's & Dementia. 5: P2-P2. DOI: 10.1016/J.Jalz.2009.05.006  0.764
2009 Lithner CU, Hernandez CM, Nordberg A, Sweatt JD. P2-146: Epigenetic changes related to beta-amyloid-implications for Alzheimer's disease Alzheimer's & Dementia. 5: P304-P304. DOI: 10.1016/J.Jalz.2009.04.457  0.382
2008 Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics. 18: 289-98. PMID 18334913 DOI: 10.1097/Fpc.0B013E3282F63F29  0.388
2008 Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, LÃ¥ngström B, Nordberg A. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Annals of Neurology. 63: 621-31. PMID 18300284 DOI: 10.1002/Ana.21345  0.646
2008 Hedberg MM, Svedberg MM, Mustafiz T, Yu WF, Mousavi M, Guan ZZ, Unger C, Nordberg A. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Neuroscience. 152: 223-33. PMID 18164554 DOI: 10.1016/J.Neuroscience.2007.11.022  0.313
2008 Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, LÃ¥ngström B, Kilander L. In vivo amyloid imaging with PET in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 35: 100-6. PMID 17846768 DOI: 10.1007/S00259-007-0523-1  0.526
2008 Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, LÃ¥ngström B, Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging. 29: 1456-65. PMID 17499392 DOI: 10.1016/J.Neurobiolaging.2007.03.029  0.676
2008 Kadir A, Darreh-Shori T, Almkvist O, Wall A, Grut M, Strandberg B, Ringheim A, B Eriksson, Blomquist G, LÃ¥ngström B, Nordberg A. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiology of Aging. 29: 1204-17. PMID 17379359 DOI: 10.1016/J.Neurobiolaging.2007.02.020  0.598
2008 Darreh-Shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, Eriksson B, LÃ¥ngström B, Nordberg A. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine. Neurobiology of Aging. 29: 168-84. PMID 17196712 DOI: 10.1016/J.Neurobiolaging.2006.09.020  0.598
2008 Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. IC-P2-134: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T60-T60. DOI: 10.1016/J.Jalz.2008.05.2589  0.751
2008 Almkvist O, Forsberg A, Nordberg A. P3-105: Low episodic memory performance is related to high PET PIB levels in asymptomatic control subjects Alzheimer's & Dementia. 4: T549-T549. DOI: 10.1016/J.Jalz.2008.05.1670  0.548
2008 Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. P2-075: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T390-T390. DOI: 10.1016/J.Jalz.2008.05.1148  0.76
2008 Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-026: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T375-T375. DOI: 10.1016/J.Jalz.2008.05.1106  0.61
2008 Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. IC-P2-107: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T50-T50. DOI: 10.1016/J.Jalz.2008.05.100  0.595
2007 Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proceedings of the National Academy of Sciences of the United States of America. 104: 12506-11. PMID 17640880 DOI: 10.1073/Pnas.0705346104  0.336
2007 Roensch J, Crisby M, Nordberg A, Xiao Y, Zhang LJ, Guan ZZ. Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochemistry International. 50: 800-6. PMID 17412455 DOI: 10.1016/J.Neuint.2007.02.001  0.329
2007 Celsi F, Svedberg M, Unger C, Cotman CW, Carrì MT, Ottersen OP, Nordberg A, Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiology of Disease. 26: 342-52. PMID 17344052 DOI: 10.1016/J.Nbd.2006.12.022  0.371
2007 Kadir A, Darreh-Shori T, Almkvist O, Wall A, LÃ¥ngström B, Nordberg A. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. Psychopharmacology. 191: 1005-14. PMID 17310387 DOI: 10.1007/S00213-007-0725-Z  0.652
2007 Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM, Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, ... ... Nordberg A, et al. Disease mechanisms in neuroscience Neuroscientist. 13: 99. DOI: 10.1177/10738584070130020301  0.538
2007 Unger C, Hernandez C, Nordberg A, Sweatt J. P.1.01 Modification of histone H3 and H4 in the brain of Tg2576 transgenic mice – implications for Alzheimer's disease European Neuropsychopharmacology. 17: S2-S3. DOI: 10.1016/S0924-977X(07)00046-6  0.327
2006 Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiology of Disease. 24: 326-33. PMID 16973370 DOI: 10.1016/J.Nbd.2006.07.013  0.632
2006 Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, LÃ¥ngström B, Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain : a Journal of Neurology. 129: 2856-66. PMID 16854944 DOI: 10.1093/Brain/Awl178  0.688
2006 Kadir A, Almkvist O, Wall A, LÃ¥ngström B, Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology. 188: 509-20. PMID 16832659 DOI: 10.1016/J.Neuroimage.2006.04.135  0.633
2006 Unger C, Svedberg MM, Yu WF, Hedberg MM, Nordberg A. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. 317: 30-6. PMID 16354790 DOI: 10.1124/Jpet.105.098566  0.336
2006 Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, LÃ¥ngström B, Nordberg A. Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 205-18. PMID 16049637 DOI: 10.1007/S00702-005-0312-6  0.638
2006 HERHOLZ K, NORDBERG A, MASDEU J, GERHARD A, EBMEIER K, PAPPATA S, PERANI D, VANLAERE K, HALLDIN C, SALMON E. Imaging of Neurotransmitter Deficits: New Potential Biomarkers for Alzheimer’s Disease? Neurorx. 3: 412-412. DOI: 10.1016/J.Nurx.2006.05.026  0.479
2006 Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. P2-136: Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ϵ4 allele, in relation to cognitive function and cerebral glucose metabolism Alzheimer's & Dementia. 2: S273-S273. DOI: 10.1016/J.Jalz.2006.05.974  0.611
2006 Kadir A, Schöll M, Forsberg A, Wall A, Långström B, Nordberg A. IC-P-010: Age and ApoE interaction in Alzheimer’s disease: FDG PET study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.2215  0.654
2006 Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-304: PET imaging of cortical 11 C-nicotine binding correlates with cognitive function of attention in Alzheimer's disease Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1144  0.633
2006 Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. P2-303: Amyloid depositions in MCI-patients studied with PIB-PET Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1143  0.633
2006 Scholl M, Kadir A, Forsberg A, Wall A, Langstrom B, Nordberg A. P2-267: Regional cerebral glucose metabolism (CMRGLC) as measured BY 18FDG-PET and Abeta1-42 and tau levels in CSF of Alzheimer patients who are carriers or non-carriers of the APOE ε4 allele genotype Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1106  0.683
2005 Unger C, Hedberg MM, Mustafiz T, Svedberg MM, Nordberg A. Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels. Molecular and Cellular Neurosciences. 30: 218-27. PMID 16107318 DOI: 10.1016/J.Mcn.2005.07.012  0.313
2005 Francis PT, Nordberg A, Arnold SE. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends in Pharmacological Sciences. 26: 104-11. PMID 15681028 DOI: 10.1016/J.Tips.2004.12.010  0.421
2004 Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 256: 240-6. PMID 15324367 DOI: 10.1111/J.1365-2796.2004.01380.X  0.543
2004 Almkvist O, Darreh-Shori T, Stefanova E, Spiegel R, Nordberg A. Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 11: 253-61. PMID 15061827 DOI: 10.1046/J.1468-1331.2003.00757.X  0.612
2004 Darreh-Shori T, Hellström-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. Journal of Neurochemistry. 88: 1102-13. PMID 15009666 DOI: 10.1046/J.1471-4159.2003.02230.X  0.385
2004 Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology. 55: 306-19. PMID 14991808 DOI: 10.1002/Ana.20009  0.459
2004 Stefanova E, Axelman K, Almkvist O, Wall A, Lannfelt L, Lngström B, Nordberg A. P3-083 FDG PET reveals decreased cerebral glucose metabolism in presymptomatic carriers of the HIS163TYR mutation in the presenilin-1 gene at risk for developing familial Alzheimer's disease Neurobiology of Aging. 25: S377. DOI: 10.1016/S0197-4580(04)81235-1  0.616
2004 Nordberg A, Engler H, Blomqvist G, Almkvist O, Ausén B, Wall A, Lngström B. O3-03-08 Imaging of amyloid in brain in vivo in MCI and AD patients Neurobiology of Aging. 25: S59. DOI: 10.1016/S0197-4580(04)80198-2  0.605
2003 Klunk WE, Engler H, Nordberg A, Bacskai BJ, Wang Y, Price JC, Bergström M, Hyman BT, LÃ¥ngström B, Mathis CA. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography. Neuroimaging Clinics of North America. 13: 781-9, ix. PMID 15024961 DOI: 10.1016/S1052-5149(03)00092-3  0.486
2003 Stefanova E, Blennow K, Almkvist O, Hellström-Lindahl E, Nordberg A. Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients. Neuroscience Letters. 338: 159-63. PMID 12566177 DOI: 10.1016/S0304-3940(02)01384-8  0.634
2002 Darreh-Shori T, Almkvist O, Guan ZZ, Garlind A, Strandberg B, Svensson AL, Soreq H, Hellström-Lindahl E, Nordberg A. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology. 59: 563-72. PMID 12196650 DOI: 10.1212/Wnl.59.4.563  0.556
2002 Marutle A, Unger C, Hellström-Lindahl E, Wang J, Puoliväli J, Tanila H, Nordberg A, Zhang X. Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neuroscience Letters. 328: 269-72. PMID 12147323 DOI: 10.1016/S0304-3940(02)00546-3  0.31
2002 Bednar I, Paterson D, Marutle A, Pham TM, Svedberg M, Hellström-Lindahl E, Mousavi M, Court J, Morris C, Perry E, Mohammed A, Zhang X, Nordberg A. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Molecular and Cellular Neurosciences. 20: 354-65. PMID 12093166 DOI: 10.1006/Mcne.2002.1112  0.307
2002 Nordberg A, Hellström-Lindahl E, Lee M, Johnson M, Mousavi M, Hall R, Perry E, Bednar I, Court J. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). Journal of Neurochemistry. 81: 655-8. PMID 12065674 DOI: 10.1046/J.1471-4159.2002.00874.X  0.384
2001 Arnáiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 12: 851-5. PMID 11277595 DOI: 10.1097/00001756-200103260-00045  0.619
2001 Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dementia and Geriatric Cognitive Disorders. 12: 22-32. PMID 11125238 DOI: 10.1159/000051232  0.569
2000 Algotsson A, Nordberg A, Winblad B. Apolipoprotein E varepsilon4 allele has an impact on vascular reactivity in Alzheimer's disease. Archives of Gerontology and Geriatrics. 31: 221-231. PMID 11154777 DOI: 10.1016/S0167-4943(00)00082-0  0.358
2000 Dierks T, Jelic V, Pascual-Marqui RD, Wahlund L, Julin P, Linden DE, Maurer K, Winblad B, Nordberg A. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 1817-24. PMID 11018498 DOI: 10.1016/S1388-2457(00)00427-2  0.398
2000 Sihver W, Nordberg A, Långström B, Mukhin AG, Koren AO, Kimes AS, London ED. Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behavioural Brain Research. 113: 143-57. PMID 10942041 DOI: 10.1016/S0166-4328(00)00209-6  0.321
2000 Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiology of Aging. 21: 533-40. PMID 10924766 DOI: 10.1016/S0197-4580(00)00153-6  0.592
2000 Winblad B, Nordberg A. New avenues in the treatment of dementia European Neuropsychopharmacology. 10: 191. DOI: 10.1016/S0924-977X(00)80099-1  0.301
1999 Sihver W, Fasth KJ, Ogren M, Lundqvist H, Bergström M, Watanabe Y, Långström B, Nordberg A. In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys. Nuclear Medicine and Biology. 26: 633-40. PMID 10587101 DOI: 10.1016/S0969-8051(99)00034-7  0.316
1999 Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dementia and Geriatric Cognitive Disorders. 10: 526-33. PMID 10559570 DOI: 10.1159/000017200  0.637
1999 Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 10: 494-504. PMID 10559566 DOI: 10.1159/000017196  0.636
1999 Sihver W, Fasth KJ, Horti AG, Koren AO, Bergström M, Lu L, Hagberg G, Lundqvist H, Dannals RF, London ED, Nordberg A, Långström B. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain. Journal of Neurochemistry. 73: 1264-72. PMID 10461920 DOI: 10.1046/J.1471-4159.1999.0731264.X  0.306
1999 Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology. 52: 1861-70. PMID 10371535 DOI: 10.1212/Wnl.52.9.1861  0.588
1999 Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Nordberg A, et al. Contents Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 553-555. DOI: 10.1159/000017205  0.456
1999 Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Nordberg A, et al. Subject Index Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 551-552. DOI: 10.1159/000017204  0.471
1998 Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neuroscience Letters. 254: 85-8. PMID 9779926 DOI: 10.1016/S0304-3940(98)00669-7  0.573
1998 Nordberg A, Amberla K, Shigeta M, Lundqvist H, Viitanen M, Hellström-Lindahl E, Johansson M, Andersson J, Hartvig P, Lilja A, LÃ¥ngström B, Winblad B. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Disease and Associated Disorders. 12: 228-37. PMID 9772028 DOI: 10.1097/00002093-199809000-00017  0.357
1998 Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 9: 246-57. PMID 9701676 DOI: 10.1159/000017069  0.325
1997 Bäckman L, Almkvist O, Andersson J, Nordberg A, Winblad B, Reineck R, Långström B. Brain activation in young and older adults during implicit and explicit retrieval. Journal of Cognitive Neuroscience. 9: 378-91. PMID 23965013 DOI: 10.1162/Jocn.1997.9.3.378  0.503
1997 Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund LO. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 59-65. PMID 9221969 DOI: 10.1136/Jnnp.63.1.59  0.381
1997 Corder EH, Jelic V, Basun H, Lannfelt L, Valind S, Winblad B, Nordberg A. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Archives of Neurology. 54: 273-7. PMID 9074396 DOI: 10.1001/Archneur.1997.00550150035013  0.429
1996 Algotsson A, Nordberg A, Lannfelt L, Almkvist O, Winblad B. Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease. Archives of Gerontology and Geriatrics. 22: 223-32. PMID 15374172 DOI: 10.1016/0167-4943(96)00695-4  0.569
1996 Jönhagen M, Wahlund LO, Amberla K, Ebendal T, Meyersson B, Nordberg A, Olson L, Shigeta M, Seiger Å, Viitanen M, Winblad B. 645 Nerve Growth Factors as a Treatment of Alzheimer's Disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80647-6  0.325
1996 Jelic V, Almkvist O, Julin P, Wahlund L, Winblad B, Nordberg A. 367 Patterns of brain metabolism in patients with mild cognitive impairment Neurobiology of Aging. 17: S92. DOI: 10.1016/S0197-4580(96)80369-1  0.554
1995 Algotsson A, Nordberg A, Almkvist O, Winblad B. Skin vessel reactivity is impaired in Alzheimer's disease. Neurobiology of Aging. 16: 577-82. PMID 8544908 DOI: 10.1016/0197-4580(95)00077-R  0.583
1993 Warpman U, Alafuzoff I, Nordberg A. Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease. Neuroscience Letters. 150: 39-43. PMID 8469400 DOI: 10.1016/0304-3940(93)90103-R  0.349
1993 Amberla K, Nordberg A, Viitanen M, Winblad B. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data. Acta Neurologica Scandinavica. Supplementum. 149: 55-7. PMID 8128841 DOI: 10.1111/J.1600-0404.1993.Tb04257.X  0.358
1993 Seiger A, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behavioural Brain Research. 57: 255-61. PMID 8117429 DOI: 10.1016/0166-4328(93)90141-C  0.38
1993 Nordberg A, Hartvig P, Andersson J, Lundqvist H, Vittanen M, Långström B, Winblad B. Visualization of muscarinic receptors in Alzheimer brains in vivo by positron emission tomography Life Sciences. 52: 556. DOI: 10.1016/0024-3205(93)90329-2  0.372
1992 Nordberg A, Alafuzoff I, Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. Journal of Neuroscience Research. 31: 103-11. PMID 1613816 DOI: 10.1002/Jnr.490310115  0.302
1992 Svensson AL, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists. Brain Research. 596: 142-8. PMID 1467980 DOI: 10.1016/0006-8993(92)91541-L  0.31
1992 Svensson A, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer brains Neurobiology of Aging. 13: S132. DOI: 10.1016/0197-4580(92)90649-I  0.338
1990 Nordberg A, Adem A, Nilsson-HÃ¥kansson L, Bucht G, Hartvig P, Alafuzoff I, Viitanen M, LÃ¥ngström B, Winblad B. New approaches to clinical and postmortem investigations of cholinergic mechanisms. Progress in Brain Research. 84: 313-20. PMID 2267305 DOI: 10.1016/S0079-6123(08)60915-2  0.319
1990 Sakurada T, Alufuzoff I, Winblad B, Nordberg A. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Research. 521: 329-32. PMID 1698512 DOI: 10.1016/0006-8993(90)91561-T  0.428
1989 Nordberg A, Nilsson-HÃ¥kansson L, Adem A, Hardy J, Alafuzoff I, Lai Z, Herrera-Marschitz M, Winblad B. The role of nicotinic receptors in the pathophysiology of Alzheimer's disease. Progress in Brain Research. 79: 353-62. PMID 2685906 DOI: 10.1016/S0079-6123(08)62495-4  0.308
1988 Nordberg A, Adem A, Hardy J, Winblad B. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains Neuroscience Letters. 86: 317-321. PMID 3380323 DOI: 10.1016/0304-3940(88)90503-4  0.335
1986 Nordberg A, Alafuzoff I, Winblad B. Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type. Neuroscience Letters. 70: 160-4. PMID 3774212 DOI: 10.1016/0304-3940(86)90456-8  0.396
1983 Nordberg A, Larsson C, Adolfsson R, Alafuzoff I, Winblad B. Muscarinic receptor compensation in hippocampus of Alzheimer patients. Journal of Neural Transmission. 56: 13-9. PMID 6133910 DOI: 10.1007/Bf01243370  0.319
Show low-probability matches.